These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18313860)

  • 41. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treating the substance-abusing suicidal patient.
    Cornelius JR; Salloum IM; Lynch K; Clark DB; Mann JJ
    Ann N Y Acad Sci; 2001 Apr; 932():78-90; discussion 91-3. PubMed ID: 11411192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.
    Levin FR; Mariani JJ; Brooks DJ; Pavlicova M; Cheng W; Nunes EV
    Drug Alcohol Depend; 2011 Jul; 116(1-3):142-50. PubMed ID: 21310551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacotherapies for cannabis dependence.
    Nielsen S; Gowing L; Sabioni P; Le Foll B
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD008940. PubMed ID: 30687936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
    Allsop DJ; Copeland J; Lintzeris N; Dunlop AJ; Montebello M; Sadler C; Rivas GR; Holland RM; Muhleisen P; Norberg MM; Booth J; McGregor IS
    JAMA Psychiatry; 2014 Mar; 71(3):281-91. PubMed ID: 24430917
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lithium carbonate in the management of cannabis withdrawal in humans: an open-label study.
    Winstock AR; Lea T; Copeland J
    J Psychopharmacol; 2009 Jan; 23(1):84-93. PubMed ID: 18515451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings.
    Trigo JM; Lagzdins D; Rehm J; Selby P; Gamaleddin I; Fischer B; Barnes AJ; Huestis MA; Le Foll B
    Drug Alcohol Depend; 2016 Apr; 161():298-306. PubMed ID: 26925704
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of fluoxetine, indomethacine and placebo on 3 alpha, 5 alpha tetrahydroprogesterone (THP) plasma levels in uncomplicated alcohol withdrawal.
    Romeo E; Pompili E; di Michele F; Pace M; Rupprecht R; Bernardi G; Pasinib A
    World J Biol Psychiatry; 2000 Apr; 1(2):101-4. PubMed ID: 12607205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dependence on cannabis--an ever lasting issue.
    Soellner R
    Subst Use Misuse; 2005; 40(6):857-67. PubMed ID: 15974145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Letter to the Editor: CONVERGENCES AND DIVERGENCES IN THE ICD-11 VS. DSM-5 CLASSIFICATION OF MOOD DISORDERS.
    Cerbo AD
    Turk Psikiyatri Derg; 2021; 32(4):293-295. PubMed ID: 34964106
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacotherapies for cannabis dependence.
    Marshall K; Gowing L; Ali R; Le Foll B
    Cochrane Database Syst Rev; 2014; 12(12):CD008940. PubMed ID: 25515775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Concordance between DSM-5 and DSM-IV nicotine, alcohol, and cannabis use disorder diagnoses among pediatric patients.
    Kelly SM; Gryczynski J; Mitchell SG; Kirk A; O'Grady KE; Schwartz RP
    Drug Alcohol Depend; 2014 Jul; 140():213-6. PubMed ID: 24793367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis.
    Bahji A; Stephenson C; Tyo R; Hawken ER; Seitz DP
    JAMA Netw Open; 2020 Apr; 3(4):e202370. PubMed ID: 32271390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparing factor, class, and mixture models of cannabis initiation and DSM cannabis use disorder criteria, including craving, in the Brisbane longitudinal twin study.
    Kubarych TS; Kendler KS; Aggen SH; Estabrook R; Edwards AC; Clark SL; Martin NG; Hickie IB; Neale MC; Gillespie NA
    Twin Res Hum Genet; 2014 Apr; 17(2):89-98. PubMed ID: 24588857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gender differences among treatment-seeking adults with cannabis use disorder: Clinical profiles of women and men enrolled in the achieving cannabis cessation-evaluating N-acetylcysteine treatment (ACCENT) study.
    Sherman BJ; McRae-Clark AL; Baker NL; Sonne SC; Killeen TK; Cloud K; Gray KM
    Am J Addict; 2017 Mar; 26(2):136-144. PubMed ID: 28152236
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabis dimensionality: dependence, abuse and consumption.
    Beseler CL; Hasin DS
    Addict Behav; 2010 Nov; 35(11):961-9. PubMed ID: 20598807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol.
    Compton WM; Dawson DA; Goldstein RB; Grant BF
    Drug Alcohol Depend; 2013 Sep; 132(1-2):387-90. PubMed ID: 23642316
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictors and Moderators of Relapse in Children and Adolescents With Major Depressive Disorder.
    Kennard BD; Mayes TL; Chahal Z; Nakonezny PA; Moorehead A; Emslie GJ
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29474007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.